LAVOLPE, Vito Grazio
 Distribuzione geografica
Continente #
NA - Nord America 915
EU - Europa 310
AS - Asia 203
AF - Africa 1
OC - Oceania 1
Totale 1.430
Nazione #
US - Stati Uniti d'America 913
CN - Cina 107
SE - Svezia 94
SG - Singapore 56
DE - Germania 46
IT - Italia 37
UA - Ucraina 33
VN - Vietnam 30
GB - Regno Unito 29
FI - Finlandia 21
BE - Belgio 16
RU - Federazione Russa 16
FR - Francia 7
HK - Hong Kong 5
IN - India 4
NL - Olanda 3
CA - Canada 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
LT - Lituania 2
AU - Australia 1
IR - Iran 1
NG - Nigeria 1
Totale 1.430
Città #
Chandler 117
Fairfield 106
Woodbridge 85
Jacksonville 77
Nyköping 67
Houston 57
Ann Arbor 55
Singapore 51
Ashburn 48
Seattle 39
Wilmington 36
Beijing 32
Cambridge 31
Dong Ket 28
Bari 21
Kansas City 19
Brooklyn 17
Brussels 16
Lawrence 16
Nanjing 16
Roxbury 16
New York 15
Des Moines 13
Boardman 10
Hebei 10
Munich 10
Jiaxing 9
Princeton 9
San Diego 7
Shanghai 5
Los Angeles 4
Ningbo 4
Pune 4
Shenyang 4
West Jordan 4
Brescia 3
Grafing 3
Paris 3
Tianjin 3
Zhengzhou 3
Amsterdam 2
Brno 2
Changsha 2
Dearborn 2
Dublin 2
Hanoi 2
Helsinki 2
Hong Kong 2
London 2
Modena 2
Nanchang 2
Redwood City 2
Rome 2
Santa Clara 2
St Albans 2
Taizhou 2
Toronto 2
Boydton 1
Chiswick 1
Chongqing 1
Düsseldorf 1
Elk Grove Village 1
Frankfurt am Main 1
Fuzhou 1
Gloucester 1
Guangzhou 1
Hefei 1
Inglewood 1
Jinan 1
Kilburn 1
Lagos 1
Manchester 1
Marseille 1
Milan 1
New Bedfont 1
Nuremberg 1
Ostuni 1
Redmond 1
Romola 1
Sabz 1
Saint Petersburg 1
Santa Marinella 1
Segrate 1
St Petersburg 1
Strasbourg 1
Sydney 1
Tappahannock 1
Trani 1
Utrecht 1
Uxbridge 1
Washington 1
Wuxi 1
Totale 1.142
Nome #
1 - 10 of 10 One page. 1: Molecular analysis in a family presenting with a mild form of late-onset autosomal dominant chronic progressive external ophthalmoplegia 179
The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy 110
null 109
A case of unilateral burning mouth syndrome of neuropathic origin 107
Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies 98
Expression of biomarkers of interferon type I in patients suffering from chronic diseases 97
A Case of Unilateral Burning Mouth Syndrome of Neuropathic Origin 91
Effects of preservation solutions on blood 88
Neutralizing and binding antibodies to interferon beta in patients with multiple sclerosis: a comparison of assay results from three italian centres 80
A case of vacuolar myopathy during the course of chronic hepatitis C 78
C'era una volta la Didattica...e adesso? 76
CORRELATIONS BETWEEN NEUTRALIZING ANTIBODIES PRODUCTION AND CLINICAL OUTCOMES: ANALYSIS IN A POPULATION- BASED SURVEILLANCE ITALIAN STUDY OF INTERFERON BETA TREATMENT IN MULTIPLE SCLEROSIS PATIENTS 60
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations 49
L'open access e l'Università. Il modello proposto dalla Facoltà di Medicina e Chirurgia di Bari 47
Università e modelli di web-leasrning 38
Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients 36
Left ventricular dysfunction in cardiac metastatic melanoma: nivolumab induced immunotoxicity or direct myocardial damage? 32
Pulmonary arterial hypertension and hiv infection 29
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study. 27
Wath's behind pericardial effusion? A difficult differential diagnosis 16
Totale 1.447
Categoria #
all - tutte 5.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.709


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020148 0 0 0 0 0 0 31 21 32 17 43 4
2020/2021214 20 7 33 10 17 4 17 9 22 26 9 40
2021/2022148 9 12 0 8 5 10 6 7 6 23 28 34
2022/2023321 46 57 18 25 47 32 3 34 51 3 3 2
2023/2024111 8 21 5 14 7 23 5 3 2 5 8 10
2024/2025111 10 8 33 36 5 19 0 0 0 0 0 0
Totale 1.447